After its discovery, trials began through the Addiction Research Center at the Federal Narcotics Hospital in Lexington, Kentucky. This includes less respiratory depression compared to full agonists, as well as a blockade of opioid effects at adequate doses (similar to the antagonist naltrexone) due to its high receptor affinity 29. Long serum half-life (approximately hours…
Read More